NEUROONE MEDICAL TECHNOLOGIES Corp

NMTC Nasdaq CIK: 0001500198

Company Information

Industry Surgical & Medical Instruments & Apparatus
SIC Code 3841
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 7599 ANAGRAM DR, EDEN PRAIRIE, MN, 55344
Mailing Address 7599 ANAGRAM DR, EDEN PRAIRIE, MN, 55344
Phone (952) 426-1383
Fiscal Year End 0930
EIN 270863354

Financial Overview

FY2025 FY

$9.10M
Revenue

Recent SEC Filings

Form Type Date Filed Document
8-K Current report of material events April 3, 2026 View on SEC
4 Insider stock transaction report April 1, 2026 View on SEC
4 Insider stock transaction report April 1, 2026 View on SEC
4 Insider stock transaction report April 1, 2026 View on SEC
4 Insider stock transaction report March 16, 2026 View on SEC
4 Insider stock transaction report March 12, 2026 View on SEC
DEF 14A Definitive proxy statement March 9, 2026 View on SEC
3 Initial insider ownership report March 3, 2026 View on SEC
4 Insider stock transaction report March 3, 2026 View on SEC
8-K Current report of material events February 25, 2026 View on SEC

Annual Reports

10-K December 17, 2025
  • Successfully selling technology in the United States is a big focus.
  • Working closely with partners like Zimmer, Inc. for product development and distribution.
View Analysis

Material Events

8-K Strategy Change April 3, 2026
High Impact
  • Shareholders approved a reverse stock split (1-for-2 to 1-for-15) to maintain Nasdaq compliance.
  • Expanded 2025 Equity Incentive Plan adds 4.5 million shares for employee compensation.
View Analysis

Insider Trading

BUY 2 insiders 6 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 3841)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.